Severe Neurological Involvement in an Adult with Shiga Toxin-Producing Escherichia coli-Hemolytic Uremic Syndrome Treated with Eculizumab
Case Reports in Nephrology and Dialysis · 27.01.2023 · 13 (1) · 7-14
DOI: 10.1159/000528893 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Nephrology and Dialysis, online erschienen am 27.01.2023. Verfasst von Pauline Vanesse und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A 68-year-old man with a medical history of hypertension was admitted to the emergency department for diffuse abdominal pain preceded by bloody diarrhea. Upon admission, neurological examination was normal, but he suddenly developed a left-sided hemiparesis. After a normal brain computed tomography, intravenous thrombolysis was administered for a suspicion of ischemic stroke. In the first laboratory investigations, hemoglobin was 16.9 g/dL, platelets 121 × 109/L (150–450), and serum creatinine 1.17 mg/dL. By the second hospital day, the platelet level dropped to 79 × 109/L, with haptoglobin at 0.12 g/L, 3% schistocytes, and normal ADAMTS13 activity (57%). Serum creatinine increased to 1.84 mg/dL with oliguria. The suspicion of thrombotic microangiopathy was supported by the identification of Shiga toxin genes stx1 and stx2 on a rectal swab and the isolation of an eaeA-negative Shiga toxin-producing E. coli O113:H4. The patient presented a generalized tonic-clonic seizure, and orotracheal intubation was required for decreased consciousness. Plasma exchange therapy was started, and eculizumab was given 6 days after symptoms onset. Brain magnetic resonance imaging (MRI) on day 13 showed symmetric hyperintensities within basal ganglia that disappeared on a second MRI on day 37. At 2-month follow-up, the patient had made a complete neurological and renal recovery and eculizumab therapy was stopped.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- Department of Neuroradiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- Department of Microbiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- Department of Microbiology and Infection Control, Belgian National Reference Centre for STEC/VTEC, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
- Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium.
Zitieren
APA
Vanesse, P., Georgery, H., Duprez, T., Gérard, L., Collienne, C., Verroken, A., Crombé, F., Morelle, J., & Hantson, P. (2023). Severe Neurological Involvement in an Adult with Shiga Toxin-Producing Escherichia coli-Hemolytic Uremic Syndrome Treated with Eculizumab. Case Reports in Nephrology and Dialysis, 13(1), 7-14. https://doi.org/10.1159/000528893
Vancouver
Vanesse P, Georgery H, Duprez T, Gérard L, Collienne C, Verroken A, et al. Severe Neurological Involvement in an Adult with Shiga Toxin-Producing Escherichia coli-Hemolytic Uremic Syndrome Treated with Eculizumab. Case Reports in Nephrology and Dialysis. 2023;13(1):7-14. doi:10.1159/000528893
BibTeX
@article{Vanesse2023,
author = {Vanesse, Pauline and Georgery, Hélène and Duprez, Thierry and Gérard, Ludovic and Collienne, Christine and Verroken, Alexia and Crombé, Florence and Morelle, Johann and Hantson, Philippe},
title = {Severe Neurological Involvement in an Adult with Shiga Toxin-Producing Escherichia coli-Hemolytic Uremic Syndrome Treated with Eculizumab},
journal = {Case Reports in Nephrology and Dialysis},
year = {2023},
volume = {13},
number = {1},
pages = {7--14},
doi = {10.1159/000528893}
}
EUVIMED